- Live Stories
- Young Minds
Remdesivir not magic bullet for COVID-19, it has harmful effects: AIIMS Director
NITI Aayog member (Health) Dr VK Paul dismissed reports that claimed the second wave is affecting the youth
Remdesivir is not a magic bullet and it cannot decrease the mortality rate, said AIIMS Director Dr Randeep Guleria, amid mass hysteria for the life-saving drug across India as many states reported a shortage. “It’s important to understand that Remdesivir is not a magic bullet and is not a drug that decreases mortality. We may use it as we don’t have an antiviral drug (yet).
“It is of no use if given early to asymptomatic individuals or those with mild symptoms. Also of no use, if given late,” he asserted.
Speaking on how India’s COVID-19 management has changed, AIIMS Director Dr Randeep Guleria said, “In the last one year of COVID management, we have learnt that two things are most important – drugs and timing of drugs. If you give them (COVID-19 drugs) too early or late, it would cause harm. Giving a cocktail of drugs on Day 1 can kill your patient and would be more harmful.”
“Recovery trials showed that steroids will benefit but it’s also important to know when they’re given. If given early before your saturation (O2) falls, it has harmful effects. COVID patients who got steroids early had higher mortality than those who didn’t,” the AIIMS Director added.
On the other hand, NITI Aayog member (Health) Dr VK Paul dismissed reports that claimed the second wave is affecting the youth and said there was no excess in the rate at which young people tested positive for coronavirus this year.
Notably, the Delhi government has set up two control rooms for monitoring and managing the supply of “COVID-19 management drugs”, amid a tsunami of coronavirus cases in the national capital.